Dexlansoprazole Reference standard

Product name : Dexlansoprazole Reference standard

CAS : 138530-94-6

Molecular formula : C₁₆H₁₄F₃N₃O₂S

Molar mass:369.363

Product description :
Dexlansoprazole (INN, trade names Kapidex, Dexilant) is a proton pump inhibitor that is marketed by Takeda Pharmaceuticals. Chemically, it is an enantiomer of lansoprazole. The compound was launched in the US for use in the treatment and maintenance of patients with erosive oesophagitis and non-erosive gastro-oesophageal reflux disease (GERD or GORD). Dexlansoprazole was approved by the U.S. Food and Drug Administration (FDA) on January 30, 2009.